Chinese English Japanese Korean

hubei PharmaStandard Co., Ltd.

Firmenname:hubei PharmaStandard Co., Ltd.
Telefon:027-19050701
E-Mail:cbbspring@163.com
Nationalität:China
URL: www.hbpharmastandard.com
Produkte insgesamt:371
1 2 3 4

Produktkatalog

β-NETA31059-54-8C16H20NO.I
Pantothenicacid calciumsalt impurity B
Rivaroxaban impurityA865479-71-6C19H18ClN3O5S
Norfloxacin impurity C177554-64-2C20H27N5O3
Topiroxostat impurity 20161233-97-2C7H4N2O2
Pantothenicacid calciumsalt impurity G2140-53-6C6H12N2O3
Tolterodine impurity Z17; 2-(3-amino-1-phenylpropyl)-4-methylphenol hydrochloride
formoterol impurity I67346-50-3C19H24N2O4
Pantothenicacid calciumsalt impurity Z04; ethyl (R)-3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoate
Milrinone impurity Z102153433-47-5C14H15N3O2
Rivaroxaban impurityE1415566-28-7C19H19N3O5S
Tolterodine impurity Z141380491-70-2C26H37NO3
Rivaroxaban impurityB1429334-00-8C16H19N3O5
Topiroxostat impurity 164329-78-6C12H9N5
Norfloxacin impurity G70459-04-0C17H18FN3O4
Milrinone impurity Z0580047-38-7C12H10N2O3
Topiroxostat impurity 192044706-68-3C13H8N6
Norfloxacin impurity Z13; 9-chloro-6-ethyl-8-fluoro-4-oxo-4,6-dihydro-2H-1l3,2l4-[1,3,2]dioxaborinino[5,6-c]quinoline-2,2-diyl diacetate
Krass intermediate 012936672-10-3
Milrinone impurity Z116302-03-0C8H9NO
Tolterodine impurity A124937-73-1C17H20O2
Sitagliptin impurity FP-D1253056-18-6C16H12F6N4O
Sitagliptin impurity B486460-31-5C16H16F5N5O
Tolterodine impurity Z07380636-49-7C23H33NO4
Norfloxacin impurity D75001-82-0C15H18FN3O
Rivaroxaban impurityJ1632463-24-1C38H36Cl2N6O10S2
formoterol impurity E1616967-26-0C20H26N2O4
Tolterodine impurity D; N-isopropyl-3-(2-methoxy-5-methylphenyl)-3-phenylpropan-1-amine hydrochloride1391053-65-8C20H27NO
Milrinone impurity Z0680442-07-5C14H14N2O3
Rivaroxaban impurity01;C24H19Cl2N3O6S2
Milrinone impurity Z126302-02-9C8H9NO
Topiroxostat impurity 132044706-50-3C13H12N8
Rivaroxaban impurity021879933-39-7C28H34N6O8
2936672-09-0
Sitagliptin impurity FP-E936630-57-8C10H10F3NO2
Rivaroxaban impurityF24065-33-6C5H3ClO2S
Tolterodine impurity Z10848768-06-9C29H37NO
Topiroxostat impurity 0238634-05-8C12H10N6
Norfloxacin impurity Z0475001-63-7C12H11FN2O3
formoterol impurity H1337876-26-2C26H30N2O4
Topiroxostat impurity 012044704-74-5C13H7N5O
Tolterodine impurity C1161940-88-0C22H31NO
Pantothenicacid calciumsalt impurity Cα-Hydroxy-β,β-dimethyl-γ-butyrolacton599-04-2C6H10O3
Tolterodine impurity Z12851789-43-0C16H18O2
Rivaroxaban impurityD1365267-35-1C29H32N6O9
RO51660171048346-74-2C12H17N3O
Topiroxostat impurity 1736770-53-3C12H9N5O
Topiroxostat impurity 10577778-82-6C13H8N6O
Norfloxacin impurity H105440-01-5C19H22FN3O5
Sitagliptin impurity FP-C1803026-58-5C16H12F6N4O
Topiroxostat impurity 0531599-25-4C12H10N6
Milrinone impurity Z02717818-05-8C7H6N4O2
Topiroxostat impurity 2321379-40-8C7H9N5O2
Pantothenicacid calciumsalt impurity H; 3-(5-(1-hydroxy-2-methylpropan-2-yl)-4-oxooxazolidin-3-yl)propanoic acid
Topiroxostat impurity 04; 4,4'-(5,5'-(pyridine-2,4-diyl)bis(4H-1,2,4-triazole-5,3-diyl))dipyridine
Topiroxostat impurity 21; 2-cyanoisonicotinamide98273-47-3C7H5N3O
Tolterodine impurity Z08854306-72-2C35H41NO2
Norfloxacin impurity J; 6,7-bis(4-(ethoxycarbonyl)piperazin-1-yl)-1-ethyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
Rivaroxaban impurity031365267-37-3C22H21N3O7
Topiroxostat impurity 071992028-94-0C13H10N6O
formoterol impurity F1795129-59-7C37H46N4O6
Sitagliptin impurity FP-A2088771-60-0C20H19F6N5O5
Topiroxostat impurity 222050015-91-1C7H6N4O
Topiroxostat impurity 18135048-32-7C7H6N4O
Tolterodine impurity E480432-14-2C19H25NO
formoterol impurity B1224588-66-2C18H22N2O4
formoterol impurity C1795135-61-3C20H26N2O4
Topiroxostat impurity 24; methyl 4-(5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)picolinate
Milrinone impurity Z09156033-07-7C12H9N3O2
Tolterodine impurity G1554029-91-2C22H32NO2+
Topiroxostat impurity 032044706-78-5C20H12N10
Norfloxacin impurity A68077-26-9C12H9ClFNO3
Sitagliptin impurity FP-B2805078-75-3C16H13F6N5O2
Rivaroxaban impurity05
Tolterodine impurity Z25109089-77-2C17H18O3
Rivaroxaban impurityH1770812-37-7C19H17Cl2N3O5S
Topiroxostat impurity 146975-73-1C6H7N3O2
β-NETA intermediate2752-87-6C15H17NO
Topiroxostat impurity 28; (Z)-isonicotinohydrazonamide
Pantothenicacid calciumsalt impurity D50692-78-9C10H19NO5
formoterol impurity G3706-26-1
Tolterodine impurity Z11209747-04-6C16H16O2
Norfloxacin impurity B75001-77-3C14H16FN3O3
Topiroxostat impurity 062044702-36-3C13H9N5O2
Rivaroxaban impurity041411775-06-8C14H17N3O4
Topiroxostat impurity 12; 2-cyano-4-(3-(1-oxidopyridin-4-yl)-1H-1,2,4-triazol-5-yl)pyridine 1-oxide
Topiroxostat impurity 112044708-04-3C7H10N6O
Pantothenicacid calciumsalt impurity E897045-90-8C12H22N2O6
Pantothenicacid calciumsalt impurity Z05N-(2-Carboxyethyl)-β-alanin505-47-5C6H11NO4
Tolterodine impurity Z0940546-94-9C16H14O2
Rivaroxaban impurityG446292-08-6C22H19N3O6
Rivaroxaban impurityK1365267-36-2C36H36N6O10
RO52633971357266-05-7C10H11FN2O
Topiroxostat impurity 091841081-71-7C13H10N6O
Sitagliptin impurity A823817-55-6C16H15F6N5O
Sitagliptin impurity C945261-48-3C16H16F5N5O
formoterol impurity D1795133-96-8C20H26N2O4
formoterol impurity A150513-24-9C18H24N2O3
Milrinone impurity Z07106637-42-7C12H9N3O
Topiroxostat impurity 25; 4-(5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)picolinohydrazide
1 2 3 4
Copyright 2019 © ChemicalBook. All rights reserved